Brand vs Corporate: A Distinction without a Difference in Social Media
"Do you want someone from corporate communications talking to your audience or should it be someone from the brand team who understands your audience and can converse with them in a...
When Big Pharma Sells Older Drugs, Is “Putting the Patient First” Devalued?
According to a Reuters article, "Leading global pharmaceutical companies have started to view their vast portfolios of older, established prescription drugs as vehicles for raising large sums of cash to fuel...
Is FDA Seeing What We’re Seeing with Its Old-School Web Browsers? Klick Health Wants...
In comments submitted to the FDA regarding recent social media guidance (read "FDA Publishes First Piece of Long-Awaited Social Media Guidance" for background), Klick Health -- an interactive agency that has...
What Pharma Can Learn from the CPG Industry About Social Media: If You “Like”...
The social networking savvy of consumer packaged goods (CPG) industry is often cited by pharma marketing consultants as something the pharmaceutical industry should emulate.
Here's what one interactive agency -- picked at...
Digital Health Coalition Urges FDA to Launch a Social Media “Laboratory” to Ensure Adequate...
In comments submitted to the FDA regarding recent social media guidance (read "FDA Publishes First Piece of Long-Awaited Social Media Guidance" for background), the Digital Health Coalition (DHC) -- comprised mostly...
BIO Mimics PhRMA’s Comments to FDA Regarding Recent SM Guidance But Is More Polite...
In its opening remarks in comments submitted to the FDA regarding recent Draft Guidance ("Guidance for Industry: Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media for Prescription Human and...
More Free Rx Drug Samples, More Branded Drug Prescriptions. Duh!
According to a study published today in JAMA Dermatology, branded and branded generic drugs (products that have novel dosage forms of off-patent products or use a trade name for a molecule...
PhRMA Questions Legality of FDA’s Recent Social Media Guidance
The FDA received about 20 comments from representatives of the pharmaceutical industry, In my last post, I summarized the comments submitted by Novartis (see "Delete This and Delete That, Says Novartis...
Delete This and Delete That, Says Novartis to FDA Regarding Recent Social Media Guidance
The comments are in! As usual, the pharma industry waited until the last second to submit comments to FDA Docket 2013-N-1430 regarding "Guidance for Industry: Fulfilling Regulatory Requirements for Postmarketing Submissions...
Total Prescriptions Written & Per Capita Spending in U.S. Rise in 2013
According to a new report issued today by the IMS Institute for Healthcare Informatics, total spending on U.S. medicines increased 1.0 percent on a real per capita basis in 2013, while...
